Related Experiment Videos
[Physical brachytherapy planning].
1Klinik für Strahlentherapie und Radiologische Onkologie, Heinrich-Heine-Universität Düsseldorf.
Praxis
|October 12, 2001
Summary
Interstitial brachytherapy offers precise prostate cancer treatment, sparing healthy organs. Advances in isotopes and planning systems are driving a resurgence in this effective technique.
Area of Science:
- Radiation Oncology
- Urology
- Medical Physics
Context:
- Prostate cancer treatment requires precise radiation delivery to the tumor while sparing surrounding organs like the bladder, rectum, and urethra.
- Interstitial brachytherapy has evolved significantly due to advancements in radioactive isotopes, treatment planning systems, and imaging technologies.
Purpose:
- To highlight the advancements and resurgence of interstitial brachytherapy for localized prostate cancer.
- To detail the role of pre- and post-treatment planning, including ultrasound, CT, and MRI, in optimizing dose delivery and quality assurance.
Summary:
- Interstitial brachytherapy enables conformal high-dose radiation for prostate cancer, sparing adjacent organs. Preoperative planning and intraoperative ultrasound-guided seed implantation with real-time dose calculation improve accuracy.
- Postoperative CT/MRI-based planning ensures dose documentation and quality assurance. Different isotopes like 192Ir (HDR), 125I, and 103Pd are used for boost or permanent implantation, with ongoing debate on isotope selection for tumor types.
- Patients can be discharged soon after permanent seed implantation due to adequate shielding by surrounding tissues. The TG43 protocol is crucial for accurate dose calculation, with potential need for 103Pd corrections.
Impact:
- Improved clinical outcomes in prostate cancer treatment through precise, conformal radiotherapy.
- Enhanced quality assurance and dose documentation via advanced imaging and planning techniques.
- Facilitates outpatient treatment and potential for further optimization of brachytherapy protocols.